Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,301,771
+$281,451 QoQ
Shares Held
32,688
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,217
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $71,666,047 across 14 Drug Manufacturers - General names. JNJ ranks #4 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
51,320 | $18,583,998 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
110,868 | $14,007,063 | |
| 3 | LLY |
ELI LILLY & Co
|
9,538 | $11,440,164 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
32,688 | $8,301,771 | |
| 5 | ABBV |
AbbVie Inc.
|
26,168 | $6,584,915 | |
| 6 | MRK |
Merck & Co., Inc.
|
33,549 | $4,311,046 | |
| 7 | BIIB |
Biogen Inc.
|
8,560 | $1,849,473 | |
| 8 | PFE |
Pfizer Inc
|
73,381 | $1,767,014 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,301,771 | 32,688 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,020,320 | 32,811 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $9,540,808 | 46,102 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,826,608 | 36,817 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,668,399 | 37,109 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,555,986 | 39,532 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,919,730 | 40,933 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,575,980 | 46,748 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,403,561 | 43,812 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,108,425 | 44,936 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $7,729,476 | 49,314 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,040,367 | 45,203 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,091,610 | 48,886 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,482,780 | 48,276 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,016,792 | 68,026 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $10,885,166 | 66,633 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $12,628,771 | 71,144 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $13,622,961 | 76,866 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $14,480,049 | 84,644 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $13,312,283 | 82,429 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,667,818 | 82,966 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $13,229,681 | 80,497 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $13,909,244 | 88,380 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $12,990,524 | 87,255 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,328,650 | 101,889 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $10,323,864 | 78,730 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||